1. DEPRESSIVE DISORDER SCHIZOPHRENIA 12Q1326

2. PATIENT DEMOGRAPHIC DETAILS:
NAME: Sabamna ishwarappa madagi
AGE: 60yrs
GENDER: Female
I.P.NO: 29875
D.O.A: D.O.D:
SCENARIO: Here is the female patient of age 60yrs admitted in female ward diagnosed as depressive disorder schizophrenia hospitalized for 5 days.
CHEIF COMPLAINTS:
c/o headache since 1 month
c/o numbness of hands since 1 month
c/o loss of appetite since 1 month

3. 5yrs back same complaints of anxiety LABORATORY INVESTIGATIONS:
HISTORY OF PRESENT ILLNESS: Patient was apparently alright 1 month back and she started complaining about headache,numbness of hands,loss of appetite and she admitted in hospital from 5 days.
PAST MEDICAL HISTORY:
5yrs back same complaints of anxiety
LABORATORY INVESTIGATIONS:
DIAGNOSIS: Patient was diagnosed as schizophrenia.
sno
REFERENCE VALUE
RESULT 1
Esinophils(1-4) 15 2
PCV(35-46)%
34.1

4. SOAP NOTE
SUBJECTIVE:
Here is the female patient of age 60yrs presenting with complaints of headche,numbness of hands,loss of appetite from 1 month.
OBJECTIVE:
Esinophils increased that indicates infection.
PCV decreased that indicates vitamin or mineral deficiency due to loss of appetite.

5. ASSESSMENT:
SCHIZOPHRENIA: It is a psychotic disorder marked by impaired thinking,emotions,delusions,hallucinations,bizarre thoughts,impaired psychosocial functioning.
PLAN:
sno
Trade name
Generic name
dose
indication 1 2 3 4 5
I.Pantodac 1-0-0
pantoprazole
40mg
ppi y
I.Ondem 1-1-1
ondansetron
1amp
antiemetic
I.Cefera 1-1-1
ceftriaxone
1gm
antibiotic
T.anxit
alprazolam
0.5mg
anxiety
T.Calpol stat sos
paracetamol
500mg
fever

6. sno
Trade name
Generic name
dose
indication 1 2 3 4 5 6
I.Ceftriaxone 1-0-1
ceftriaxone
1gm
antibiotic y 7
T.Lonazep 0-0-1
clonazepam
0.25mg
antiepileptic 8
t.s.celepra 0-0-1
escitalopram
1omg
Anti depressant 9
T.Pantac 1-0-0
pantoprazole
40mg
ppi

7. DRUG-INTERACTIONS:
Ondansetron+escitalopram
Major-increases serotonin syndrome together.it show symptoms like tachycardia,fever,seizure
clonazepam+escitalopram
Moderate- together may increase side effects like dizziness.

8. Patient counselling:
Cognitive-behavioral therapy should be given to prevent cognitive impairement.
Family-therapy should be given
Patient should interact with his family members to make patient active.